Jennifer Cummings, MD
Clinical Cardiac Electrophysiology · Canton, OHNPI 1235161613
Payments from drug & device makers
Across 310 payments — averaging $92.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Boehringer Ingelheim$8K
- Boston Scientific$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$3K
- Abbott$565
- Biotronik Inc.$528
- plus $2K from 21 others
Across 1 payment — averaging $800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$800
What the payments were for
- Consulting fees$70%
- Speaking & faculty fees$10,11035%
- Travel & lodging$9,74134%
- Food & beverage$8,45530%
- Education$2381%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 101 | $12,107 |
| Boehringer Ingelheim | 10 | $8,036 |
| Boston Scientific | 28 | $2,810 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 27 | $2,541 |
| Abbott | 12 | $565 |
| Biotronik Inc. | 9 | $528 |
| Amgen | 10 | $304 |
| E.r. Squibb & Sons, L.L.C. | 25 | $285 |
| Novartis | 21 | $234 |
| Astellas Pharma US Inc | 4 | $174 |
| Amarin Pharma, Inc. | 13 | $151 |
| AstraZeneca | 10 | $141 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $97 |
| Johnson & Johnson | 11 | $93 |
| Portola Pharmaceuticals, LLC | 6 | $88 |
| Atricure, Inc. | 1 | $86 |
| Abiomed | 2 | $69 |
| Sanofi-aventis U.S. LLC | 5 | $67 |
| Pfizer | 4 | $56 |
| Actelion Pharmaceuticals US, Inc. | 2 | $25 |
| Regeneron Healthcare Solutions, Inc. | 2 | $23 |
| Braemar Manufacturing, LLC | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Z-medica, LLC | 1 | $7 |
| Altathera Pharmaceuticals LLC | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRADAXA$7,979
- LifeVest$2,250
- Micra$1,861
- RHYTHMIA$917
- Repatha$227
- CardioMEMS HF System$139
- PulseSelect$131
- AVEIR$121
How this compares
$28,551 in reported general payments places this provider in the 45th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 416 | $383,793 |
| XareltoRivaroxaban | 131 | $115,941 |
| EntrestoSacubitril/Valsartan | 44 | $49,412 |
| Dofetilide | 58 | $5,851 |
| Metoprolol Succinate | 252 | $3,551 |
| Flecainide Acetate | 74 | $3,399 |
| SotalolSotalol Hcl | 147 | $3,035 |
| Midodrine Hcl | 38 | $2,557 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 52 | $1,241 |
| Sotalol AfSotalol Hcl | 24 | $831 |
| Digoxin | 33 | $733 |
| Dilt-XrDiltiazem Hcl | 15 | $629 |
| Losartan Potassium | 84 | $594 |
| Carvedilol | 59 | $569 |
| Fludrocortisone Acetate | 16 | $425 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $56 | $383,793416 claims |
| Johnson & JohnsonXarelto | $93 | $115,941131 claims |
| NovartisEntresto | $234 | $49,41244 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Canton
- Firas HamdanCanton$229K
- Walid SalibaCleveland$5.3M
- Anish AminColumbus$2.8M
- Bruce WilkoffCleveland$1.4M
- John HummelColumbus$1.4M
- Ayman HusseinCleveland$1.3M
- Gaurang GandhiCincinnati$990K
- Thomas CallahanCleveland$805K
- Laura GravelinGrove City$754K
- Auroa BadinColumbus$580K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.